Interested in surface proteomics for drug discovery?? Come to our @hupo-org.bsky.social Workshop on Sunday, Nov 9 at HUPO in Toronto! Excited to host with Amanda Lorentzain and learn from @berndwollscheid.bsky.social, Susan Klaeger and Thomas Kislinger!

CNPN2025 will be held on November 8th to kick off HUPO2025! We have the honor to introduce our keynote speaker and fantastic invited speaker 🥳 @kislingerthomas.bsky.social and @philipplange.bsky.social For more info about the program: cnpn.ca/cnpn2025/ #precisionmedicine #biomarkerdiscovery

Latest preprint from the lab. Great work as always by Meinusha. This is the last chapter for her PhD. www.biorxiv.org/content/10.1...

Checkout our latest pre-print www.biorxiv.org/content/10.1...

Phenotypic screens for SIRPA expression reveal RAB21 as a general regulator of macrophage surface identity: Cell Reports www.cell.com/cell-reports...

‪checkout our latest paper in @natbiotech.nature.com . We developed a graph-based algorithm that comprehensively generates non-canonical peptides in linear time. www.nature.com/articles/s41...

Identification of non-canonical peptides with moPepGen - @uclahealth.org @uoftmedicine.bsky.social @kislingerthomas.bsky.social go.nature.com/3HYJyyz

New collaborative work from PhD student Aastha. Using proteomics for CSF-based biomarker discovery pubmed.ncbi.nlm.nih.gov/40321620/

New review from our team. pubmed.ncbi.nlm.nih.gov/40227112/

Last paper for 2024. Nice work by PDF Matt Waas on proteomics of HNSCC tissues to identify novel biomarkers within the N0 population. Great collaboration with Laurie Ailles and support from many colleagues Princess Margaret Cancer Centre

Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers https://www.biorxiv.org/content/10.1101/2024.12.11.627962v1

Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers https://www.biorxiv.org/content/10.1101/2024.12.11.627962v1

Big effort (> 7 years) from a large number of colleagues. Finally on BioRxiv and to be submitted in January Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers www.biorxiv.org/content/10.1...

Boomerang bowl completed

A day of skiing at Lake Louise

Great talk by Meinusha winning a Lake Louise travel award #lakelouise2024

Back at the Lake Louise Tandem Mass Spec conference